Sylvain Meloche

Université de Montréal, Montréal, Canada 
Microbiology Biology, Pharmacy
"Sylvain Meloche"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Soulez M, Tanguay PL, Dô F, et al. (2022) ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation. Journal of Cellular Physiology
Guégan JP, Lapouge M, Voisin L, et al. (2022) Signaling by the tyrosine kinase Yes promotes liver cancer development. Science Signaling. 15: eabj4743
Mathien S, Tesnière C, Meloche S. (2021) Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential. Pharmacological Reviews. 73: 263-296
Aubert L, Nandagopal N, Steinhart Z, et al. (2020) Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nature Communications. 11: 3701
Soulez M, Saba-El-Leil MK, Turgeon B, et al. (2019) Reevaluation of the Role of ERK3 in Perinatal Survival and Post-Natal Growth Using New Genetically-Engineered Mouse Models. Molecular and Cellular Biology
Pyakurel A, Balmer D, Saba-El-Leil MK, et al. (2017) Loss of ERK1/2 in the retinal pigment epithelium leads to RPE65 decrease and retinal degeneration. Molecular and Cellular Biology
Sipthorp J, Lebraud H, Gilley R, et al. (2017) Visualisation of Endogenous ERK1/2 in Cells with a Bioorthogonal Covalent Probe. Bioconjugate Chemistry
Mathien S, Déléris P, Soulez M, et al. (2017) The Deubiquitinating Enzyme USP20 Regulates ERK3 Stability and Biological Activity. Molecular and Cellular Biology
Saba-El-Leil MK, Frémin C, Meloche S. (2017) Isolation of Mouse Embryonic Stem Cell Lines in the Study of ERK1/2 MAP Kinase Signaling. Methods in Molecular Biology (Clifton, N.J.). 1487: 243-253
Saba-El-Leil MK, Frémin C, Meloche S. (2016) Redundancy in the World of MAP Kinases: All for One. Frontiers in Cell and Developmental Biology. 4: 67
See more...